FDA Finds Carcinogen in Some Versions of Metformin – Diabetes Doctor

FDA Finds Carcinogen in Some Versions of Metformin


On May 27, 2020, the FDA announced certain extended-release (ER) versions of metformin tested positive for unsafe levels of N-Nitrosodimethylamine (NDMA). Metformin was recalled in both Singapore and Canada this last year because of the same concerns with NDMA contamination.

 

The World Health Organization classifies NDMA as a probable human carcinogen. Exposure to NDMA has been linked to a number of cancers and even small amounts of exposure can lead to liver damage. The EPA classifies NDMA as a B2 carcinogen, meaning it has a sufficient amount of animal data to conclude that it’s a potential carcinogen for humans.

 

This comes after Valisure Phamacy filed a petition with the FDA in March 2020 that it found high levels of NDMA in certain batches of metformin - requesting the agency to recall the contaminated products. They reported that out of 128 samples they tested distributed in the US, 36% contained levels of NDMA that exceeded daily acceptable limits set by the FDA.

24 Hour Support

Metformin would be the third widely used medication in recent years to face recalls related to NDMA – after the chemical was found in dozens of shipments of blood pressure and heartburn drugs last year, triggering recalls of Zantac (ranitidine), valsartan and losartan.

 

Apotex Corp has made their recall public. The FDA announcement did not name the other four drugmakers who have been requested to recall their products but are working with the manufacturers to determine the appropriate next steps.  It is unknown whether the recalls will lead to shortages of metformin, since there are a number of companies that make generic versions of the drug.  

 

Now what?

 

As information becomes available, pharmacies will be notified. Never discontinue your medication without first talking with your doctor. The FDA recommends that patients should continue taking metformin drugs until their doctor can prescribe a replacement, if necessary, as there can be considerable risks in stopping medications and experiencing high blood sugar levels.

 

Your pharmacy will automatically substitute any future refills with a safe manufacturer. If you have any concerns in the meantime, your pharmacist and/or prescriber should be able to work with you on an alternative option. There are safe extended-release formulations still available and there have been no reported contamination problems with immediate-release metformin.

 

Another consideration is if you take other oral diabetes medications (such as Invokana, Farxiga, Jardiance, Januvia, etc), there are combination options available that include Metformin in the same tablet … such as InvokaMet or JanuMet. These combination products have not had any reports of unsafe NDMA levels and have the added convenience of taking less pills in a day.

Read more information about Metformin benefits and risks here

13 comments

  • Anita King

    My boyfriend always complained of stomach pain. I kept telling him I think it was combination of all his medicines he was taking at one time and metformin was one of them. He stopped taking the metforem and I haven’t heard him complain anymore

  • Patricia sutherland

    I have a diabetic since 2008 I take meforment 4 tablets 2 in the morning 2 after supper type 2 diabeties. Im aboriginal native amerrican

  • COlette

    My whole family has taken this for many many many years omg prescribes by doctors

  • JOAN WALKER

    I’ve been talking this medication for a long time. The doctor had me on 2 750mg tabs but it made me so sick they cut back to 1 tab. I told them in still sick off of it. They said I needed it. I finally said I’m done. I stopped taking it just this wk.
    I can be reached at 207-944-6197. 101 Merryman Rd. Glenburn, ME 04401

  • Dave Tokar

    Been taking 2000 units a day past 3 years haven’t noticed anything different hopefully will get updates from Wallmart in Moundsville West Virginia

Leave a comment

Please note, comments must be approved before they are published


x

x